Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor | Patent Publication Number 20200253963
US 20200253963 A1Patent NumberUS 10993942 B2
Application Number16827650
Filled DateMar 23, 2020
Priority DateSep 7, 2012
Publication DateAug 13, 2020
Original AssigneeAbbvie Inc.
Roche
Roche
Current AssigneeAbbvie Inc.
Inventor/ApplicantsChristian Klein
Deepak Sampath
Wayne John Fairbrother
Rod A. Humerickhouse
Andrew W. Roberts
John F. Seymour
Sari L. Heitner Enschede
Deepak Sampath
Wayne John Fairbrother
Rod A. Humerickhouse
Andrew W. Roberts
John F. Seymour
Sari L. Heitner Enschede
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.